Department Grants

Anfisa Ayalon

Hamzah Aweidah

Spectral properties of ERG oscillatory potentials in hereditary retinal dystrophies prior to and following theapplication of gene therapy employing a novel gel-based AAV delivery system

PRPF31-associated retinal degeneration: clinical and genetic characterization in humans and gene augmentation therapy in a non-human primate model

Anthony St. Leger Contribution of sympathetic nerves to herpes stromal keratitis

Assessing how ocular surface nerves, immune cells, and epithelial cells communicate to encourage neuro-immune homeostasis

Bingjie Wang

Debasish Sinha

In Vivo Cellular Identification of RGC Degeneration and Regeneration in Rats

UPMC Immune Transplant and Therapy Center (ITTC)Cryba1 Gene Therapy for Nonexudative Age Related Macular Degeneration

Debasish Sinha Function of a lens protein betaA3/A1-crystallin in astrocytes

$397,500 Eric Romanowski In Vitro Evaluation of REMOGEN ® Omega for Indicators of Alteration of the Inflammatory Response

A Dual Antibiotic-Steroid Drug-Eluting Contact Lens for Treatment of Eye Injuries That Can Be Used in an Austere Environment or Prolonged Field Care Setting

Retinal eye-tracking as a prognostic tool for traumatic brain injury and concussion

Cross-species vascular anatomy and sensitivity to intraocular pressure in glaucoma

Jay Kumar Chhablani

Jay Kumar Chhablani

Interplay between retinal pigment epithelium, Bruch’s membrane and choriocapillaris in AMD progression: towards generation of customized “Retina-RPE-BM-CC assembloid” in vitro model

A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD

Inc.

Jose Sahel

A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate Efficacy, Safety & Tolerability of AGTC501, Compared to an Untreated Control Group in Males with X-linked RP Confirmed by a Pathogenic Variant in the RPGR Gene

Corporation (AGCT)